Filing Details

Accession Number:
0001628280-24-040837
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-09-18 17:59:00
Reporting Period:
2024-09-16
Accepted Time:
2024-09-18 17:59:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1588978 Procept Biorobotics Corp PRCT Surgical & Medical Instruments & Apparatus (3841) 260199180
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1653771 Kevin Waters C/O Procept Biorobotics Corporation
150 Baytech Drive
San Jose CA 95134
Evp, Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-09-16 15,917 $4.52 112,013 No 4 M Direct
Common Stock Acquisiton 2024-09-16 9,083 $4.56 121,096 No 4 M Direct
Common Stock Disposition 2024-09-16 6,623 $81.96 114,473 No 4 S Direct
Common Stock Disposition 2024-09-16 17,977 $82.69 96,496 No 4 S Direct
Common Stock Disposition 2024-09-16 400 $83.35 96,096 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2024-09-16 15,917 $4.52 15,917 $4.52
Common Stock Stock Option (Right to Buy) Disposition 2024-09-16 9,083 $4.56 9,083 $4.56
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2028-10-22 No 4 M Direct
44,160 2029-12-11 No 4 M Direct
Footnotes
  1. The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2024.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.30 to $82.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.30 to $83.27, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.34 to $83.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
  5. The Stock Option was granted on October 23, 2018 and vested over a four year period.
  6. The Stock option was granted on December 12, 2019 and vested over a four year period.